|
ATP2B4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.655850E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.262400E-01 |
| Normal-vs-Stage2 |
1.672010E-01 |
| Normal-vs-Stage3 |
4.753700E-02 |
| Normal-vs-Stage4 |
2.384300E-02 |
| Stage1-vs-Stage2 |
5.100500E-02 |
| Stage1-vs-Stage3 |
1.036010E-01 |
| Stage1-vs-Stage4 |
2.763600E-02 |
| Stage2-vs-Stage3 |
8.243000E-03 |
| Stage2-vs-Stage4 |
2.997500E-03 |
| Stage3-vs-Stage4 |
4.396400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.290400E-02 |
| Normal-vs-AfricanAmerican |
8.654100E-02 |
| Normal-vs-Asian |
1.919230E-01 |
| Caucasian-vs-AfricanAmerican |
2.720600E-01 |
| Caucasian-vs-Asian |
9.662000E-01 |
| AfricanAmerican-vs-Asian |
3.588400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.555500E-02 |
| Normal-vs-Female |
4.028400E-01 |
| Male-vs-Female |
7.875600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.919800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.212600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.081600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.817400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.281400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.984600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.858600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.472800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.968600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.195600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.115200E-01 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
1.635230E-01 |
| Classical-VS-Normal |
6.804000E-04 |
| Tall-VS-Follicular |
1.18571819029967E-13 |
| Tall-VS-Other |
3.919800E-02 |
| Tall-VS-Normal |
1.659510E-03 |
| Follicular-VS-Other |
4.219900E-02 |
| Follicular-VS-Normal |
4.88150000421683E-08 |
| Other-VS-Normal |
6.095000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.581170E-01 |
| Normal-vs-N1 |
1.824780E-01 |
| N0-vs-N1 |
1.356240E-02 |
|
|
